Tracking 45+ Companies & 221+ Open Roles
The career platform for psychedelic medicine
Company intelligence, jobs, clinical trials, and practitioner resources — everything you need to build a career in the emerging psychedelic industry.
45+
Companies tracked
221+
Open positions
2515
Active clinical trials
17
States with legislation
University of Texas at AustinPsilocybin · Treatment Resistant DepressionPhase 2·
Assistance Publique - Hôpitaux de ParisKetamine · Major Depressive EpisodePhase 3·
ACADIA Pharmaceuticals Inc.ACP-211 · Major Depressive Disorder (MDD)Phase 2·
Joshua Woolley, MD, PhDPsilocybin · Parkinson DiseasePhase 2·
Nantes University Hospitaldirect IV injection · Rapid Sequence InductionPhase 3·
Radboud University Medical CenterLSD tartrate · Chronic Cluster HeadachePhase 2·
Abraham NunesKetamine · Treatment Resistant DepressionPhase 3·
Carolyn Rodriguez3 · Obsessive-Compulsive DisorderPhase 2·
New York State Psychiatric InstituteCI-581-a · Opioid DependencePhase 3·
University of CincinnatiFull-band · Traumatic Brain InjuryPhase 2·
University of Texas at AustinPsilocybin · Treatment Resistant DepressionPhase 2·
Assistance Publique - Hôpitaux de ParisKetamine · Major Depressive EpisodePhase 3·
ACADIA Pharmaceuticals Inc.ACP-211 · Major Depressive Disorder (MDD)Phase 2·
Joshua Woolley, MD, PhDPsilocybin · Parkinson DiseasePhase 2·
Nantes University Hospitaldirect IV injection · Rapid Sequence InductionPhase 3·
Radboud University Medical CenterLSD tartrate · Chronic Cluster HeadachePhase 2·
Abraham NunesKetamine · Treatment Resistant DepressionPhase 3·
Carolyn Rodriguez3 · Obsessive-Compulsive DisorderPhase 2·
New York State Psychiatric InstituteCI-581-a · Opioid DependencePhase 3·
University of CincinnatiFull-band · Traumatic Brain InjuryPhase 2·
Companies
The psychedelic medicine ecosystem
Stay ahead of the industry
Get updates on new job listings, clinical trial progress, and regulatory changes across all 50 states.